Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytosorbents (CTSO) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Cytosorbents (CTSO) over the last 2 years, with Q3 2025 value amounting to $6.9 million.

  • Cytosorbents' Restructuring Costs rose 1040.23% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 million, marking a year-over-year change of. This contributed to the annual value of $23.2 million for FY2024, which is 860.66% down from last year.
  • According to the latest figures from Q3 2025, Cytosorbents' Restructuring Costs is $6.9 million, which was up 1040.23% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Restructuring Costs ranged from a high of $7.1 million in Q2 2025 and a low of $3.9 million during Q4 2024